FICARRA, Paola
 Distribuzione geografica
Continente #
NA - Nord America 4.758
EU - Europa 4.593
AS - Asia 2.614
SA - Sud America 914
AF - Africa 79
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 3
Totale 12.969
Nazione #
US - Stati Uniti d'America 4.700
RU - Federazione Russa 1.486
SG - Singapore 1.181
IE - Irlanda 841
BR - Brasile 826
CN - Cina 776
SE - Svezia 712
UA - Ucraina 478
DE - Germania 374
HK - Hong Kong 345
GB - Regno Unito 214
FI - Finlandia 204
IT - Italia 104
VN - Vietnam 69
IN - India 66
FR - Francia 50
CA - Canada 34
TR - Turchia 32
PL - Polonia 31
AR - Argentina 28
MA - Marocco 23
ZA - Sudafrica 23
IQ - Iraq 22
IR - Iran 22
BD - Bangladesh 19
EC - Ecuador 18
ES - Italia 18
MX - Messico 18
AT - Austria 13
BE - Belgio 12
JP - Giappone 12
CI - Costa d'Avorio 11
PK - Pakistan 11
CZ - Repubblica Ceca 10
NL - Olanda 10
ID - Indonesia 9
TN - Tunisia 9
CO - Colombia 8
UZ - Uzbekistan 8
VE - Venezuela 8
AZ - Azerbaigian 6
CL - Cile 6
KE - Kenya 6
LV - Lettonia 6
OM - Oman 6
PE - Perù 6
UY - Uruguay 6
AE - Emirati Arabi Uniti 5
AU - Australia 5
PY - Paraguay 5
AL - Albania 4
IL - Israele 4
RS - Serbia 4
BO - Bolivia 3
LT - Lituania 3
PH - Filippine 3
RO - Romania 3
AM - Armenia 2
BN - Brunei Darussalam 2
BY - Bielorussia 2
CH - Svizzera 2
DZ - Algeria 2
EU - Europa 2
GR - Grecia 2
JM - Giamaica 2
MD - Moldavia 2
MY - Malesia 2
NP - Nepal 2
NZ - Nuova Zelanda 2
PA - Panama 2
QA - Qatar 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
AO - Angola 1
BG - Bulgaria 1
BH - Bahrain 1
CR - Costa Rica 1
DK - Danimarca 1
EG - Egitto 1
GE - Georgia 1
HR - Croazia 1
JO - Giordania 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LB - Libano 1
LU - Lussemburgo 1
MK - Macedonia 1
MN - Mongolia 1
NG - Nigeria 1
NO - Norvegia 1
NR - Nauru 1
SA - Arabia Saudita 1
SV - El Salvador 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 12.969
Città #
Jacksonville 892
Dublin 840
Moscow 763
Chandler 530
Singapore 493
Ashburn 451
Nyköping 429
Dallas 379
Hong Kong 344
Beijing 279
Dearborn 190
Cambridge 139
Princeton 139
Medford 132
Des Moines 112
Los Angeles 103
Boardman 93
Lancaster 78
The Dalles 78
Buffalo 69
São Paulo 65
Ann Arbor 59
Jinan 59
Munich 54
Woodbridge 50
Tianjin 46
New York 40
Turku 38
Wilmington 38
Shenyang 35
Ho Chi Minh City 33
Redondo Beach 30
San Mateo 26
Augusta 25
Belo Horizonte 24
Rio de Janeiro 24
Warsaw 24
Hangzhou 23
Helsinki 23
Nanjing 23
Brasília 22
Houston 22
Pune 22
Brooklyn 21
Montreal 20
Nanchang 19
Ardabil 18
Haikou 18
Leawood 18
Bremen 17
Atlanta 16
Guangzhou 16
Campinas 15
Zhengzhou 15
Hebei 14
Phoenix 14
Vienna 13
Brussels 12
Frankfurt am Main 12
Seattle 12
Abidjan 11
Chennai 11
Denver 11
Johannesburg 11
London 11
Ningbo 11
Porto Alegre 11
San Jose 11
Taizhou 11
Tokyo 11
Goiânia 10
Manaus 10
Messina 10
Poplar 10
Auburn Hills 9
Boston 9
Fortaleza 9
Fuzhou 9
Hanoi 9
San Francisco 9
Santa Clara 9
Brno 8
Guayaquil 8
Mexico City 8
Mumbai 8
Stockholm 8
Tashkent 8
Washington 8
Baghdad 7
Casablanca 7
Chicago 7
Curitiba 7
Elk Grove Village 7
Hyderabad 7
Saint Petersburg 7
Salvador 7
Seropédica 7
Ankara 6
Aracaju 6
Baku 6
Totale 7.958
Nome #
Anticonvulsant agent: enhancement of physicochemical properties 159
AMPHIPHILIC CYCLODEXTRINS AS NANOCARRIERS OF GENISTEIN: A SPECTROSCOPIC INVESTIGATION POINTING OUT THE STRUCTURAL PROPERTIES OF THE HOST/ ISOFLAVONE COMPLEX SYSTEM IN WATER AND AT THE SOLID STATE 154
ANALYSES AND DETERMINATION OF LONIDAMINE RELEASE FROM PHARMACEUTICAL FORMULATION. 142
An experimental design methodology applied to the enantioseparation of a non-steroidal anti-inflammatory drug candidate 139
BETA-BLOCKERS CHARACTERIZATION BY UV-VIS ABSORPTION AND REFLECTIVITY IN DIFFERENT CHEMICAL ENVIRONMENTS 138
ANALYSIS OF PYRROLIDONIC COMPOUNDS AS POTENTIAL ANTIOXIDANT. 138
CARATTERIZZAZIONE DI COMPLESSI D'INCLUSIONE FLAVONOIDI/CICLODESTRINE MEDIANTE:DSC,RAGGI X,DRIFT,UV-VIS 136
Combined effect of pH and polysorbates with cyclodextrins on solubilization of naringenin 133
Comparative photodegradation studies on 3-hydroxyflavone: influence of different media, pH and light sources 133
CORDIA FRANCISCI, C, MARTINICENSIS, C. MYXA, C. SERRATIFOLIA AND C. ULMIFOLIA LEAVES AS NEW SOURCES OF RUTIN: ANALGESIC AND ANTI-INFLAMMATORY ACTIVITY. 131
Analytical profile and release of lonidamine from pharmaceutical formulation 131
ENANTIOSEPARATION AND COMPLEXATION STUDIES ON 2,3-BENZODIAZEPINES 129
A STUDY OF THE INCLUSION COMPLEX OF ATENOLOL WITH BETA-CYCLODEXTRIN 128
COMBINED EFFECT OF pH AND CYCLODEXTRINS ON SOLUBILIZATION OF NARINGENIN 128
Amphiphilic Cyclodextrins as Nanocarriers of Genistein: aSpectroscopic Investigation Pointing out the StructuralProperties of the Host/Drug Complex System 125
Study of beta-blockers/beta-cyclodextrins inclusion complex by NMR, DSC, X-ray and SEM investigation 124
COMPARATIVE PHOTODEGRADATION STUDIES: INFLUENCE OF DIFFERENT MEDIA AND LIGHT SOURCES 124
SEPARAZIONE E DETERMINAZIONE MEDIANTE HPLC IN FASE INVERSA DI DERIVATI DEL 2-FENILCROMONE E DELL'ACIDO CLOROGENICO DA ESTRATTI DI CRATAEGUS OXYACANTHA L. 123
PREPARATION AND CHARACTERIZATION OF GEMCITABINE-LOADED CHITOSAN MICROSPHERES. 122
BROTIZOLAM: ANALISI E DETERMINAZIONE MEDIANTE TECNICHE CROMATOGRAFICHE. 121
Direct separation of the enantiomers of reboxetine by liquid chromatography on different cellulose- and amylose-based chiral stationary phases 120
CHROMATOGRAPHIC INVESTIGATIONS ON BROTIZOLAM 119
CONFORMATIONAL SEARCH OF PHENYL SUBSTITUTED GAMMA-LACTAMIC DERIVATIVES. 119
Cromatografia liquida ad alta efficienza nell'analisi farmaceutica: separazione e determinazione di una miscela diuretica-antipertensiva 118
UV-vis and FTIR-ATR characterization of 9-fluorenon-2-carboxyester/(2-hydroxypropyl)-beta-cyclodextrin inclusion complex 118
Optimization of a LC method for the enantio separation of a non-competitive glutamate receptor antagonist, by experimental design methodology 118
AN EXPERIMENTAL DESIGN METHODOLOGY APPLIED TO THE CHIRAL SEPARATION OF A NON-STEROIDAL ANTI-INFLAMMATORY DRUG CANDIDATE 117
REAZIONI UV-INDOTTE:FOTOCHIMICA DI COMPLESSI D'INCLUSIONE FLAVONOIDI/CICLODESTRINE. Nota II 116
ANALISI DI FLUNARIZINA BICLORIDRATO IN FORME FARMACEUTICHE MEDIANTE CROMATOGRAFIA LIQUIDA AD ALTA PRESSIONE 115
PHYSICO-CHEMICAL CHARACTERIZATION OF AN AMPHIPHILIC CYCLODEXTRIN/GENISTEIN COMPLEX 115
OPTIMIZED ENANTIOSELECTIVE HPLC METHOD FOR THE ANALYSIS OF TETRAHYDROISOQUINOLINES 113
Variable-ionic strength kinetic experiments in drug stability studies 112
INCAPSULATION OF LUTEIN IN AMPHIPHILIC -CYCLODEXTRIN NANOPARTICLES FOR THE APPLICATION IN DRUG DELIVERY. 112
Gemcitabine-Loaded Chitosan Microspheres For Local Delivery In Lung, 112
Study of the extraction procedure by experimental design and validation of a LC method for determination of flavonoids in Citrus bergamia juice 111
Photochemistry of flavonoids. Solvent effect on photochemical behaviour of 3-hydroxyflavone. 111
RUTIN INCLUSION SYSTEMS WITH ALFA AND BETA-CYCLODEXTRINS: CIRCULAR DICHROISM, UV ABSORPTION SPECTROSCOPY AND ANTIOXIDANT ACTIVITY STUDIES 111
A CHEMOMETRIC APPROACH FOR THE SEPARATION OF SOME PSYCHOTROPIC DRUGS AND THEIR METABOLITES BY LIQUID CHROMATOGRAPHY 108
SPECTROSCOPIC INVESTIGATION OF INCLUSION COMPLEX OF 9-FLUORENONIC DERIVATIVE WITH (2-HYDROXYPROPYL)-BETA-CYD 108
Synthesis, Chiral Resolution and Pharmacological Evaluation of a 2,3-Benzodiazepine-Derived Noncompetitive AMPA Receptor Antagonist 107
The rutin/beta-cyclodextrin interactions in fully aqueous solution: spectroscopic studies and biological assays 107
Phisicochemical characterization of cumestrol beta-cyclodextrins inclusion complexes by UV-Vis anf FTIR-ATR spectyroscopies 107
INCLUSION COMPLEXES OF SOME FLAVANONES AND THEIR GLYCOSIDES WITH MODIFIED BETA-CYLODEXTRINS 106
Determination of fludarabine in a pharmaceutical formulation by LC 105
Physicochemical characterization of coumestrol/beta-cyclodextrins inclusion complexes by UV-vis and FTIR-ATR spectroscopies 104
NANOAGGREGATES OF AMPHIPHILIC CYCLODEXTRIN WITH GENISTEIN: A SPECTROSCOPY CHARACTERISATION BY UV-VIS, DYNAMIC LIGHT SCATTERING AND FTIR-ATR 104
HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY. SEPARATION AND IDENTIFICATION OF FLAVONOIDS IN CRATAEGUS OXYACANTHA L. Note IV. Apigenin, Apigenin-7-glucoside, Luteolin, Luteolin-3',7-diglucoside 102
MISURE DI LIPOFILICITA' DI FLAVONI MEDIANTE CROMATOGRAFIA LIQUIDA IN FASE INVERSA 102
GEMCITABINE-LOADED CHITOSAN MICROSPHERES FOR LOCAL DELIVERY IN LUNG 102
TECNICHE CHEMOMETRICHE PER L'OTTIMIZZAZIONE DI METODOLOGIE STRUMENTALI IN ANALISI FARMACEUTICA 101
MOLECULAR MODELING OF ENANTIOSELECTIVE RECOGNITION BETWEEN GAMMA-LACTAMIC DERIVATIVES AND CHIRALCEL OD CHIRAL STATIONARY PHASE. 99
UV-INDUCED REACTIONS:EFFECTS OF MICROENVIROMENT ON FLAVONOIDS PHOTOCHEMISTRY 99
Effects of alpha and beta-cyclodextrin complexation on the physico-chemical properties and antioxidant activity of some 3-hydroxyflavones 99
Cromatografia liquida nell'analisi farmaceutica: determinazione nelle compresse della famotidina, nuovo H2-antagonista 98
Determinazione del trans-1-bis(4-fluorofenil)metil-4-(3-fenil-2-propenil)piperazina dicloridrato mediante HPLC 98
Dosaggio mediante HPLC di atenololo e clortalidone associati in forme farmaceutiche 98
DIRECT ENANTIOMERIC SEPARATION OF REBOXETINE BY LIQUID CHROMATOGRAPHY USING DIFFERENT CELLULOSE AND AMYLOSE BASED CHIRAL STATIONARY PHASES 97
Selective reversed-phase liquid chromatography method for the kinetic investigation of 3-hydroxyflavone photostability 94
METAL-COMPLEXES OF BENZODIAZEPINES . PART 2. THE REACTION OF 1,4- BENZODIAZEPINES WITH HALIDE-BRIDGED COMPLEXES OF PALLADIUM(II) [PD2X4(PPRN3)2] (X = CL OR I) 93
Improvement in solubility and dissolution rate of flavonoids by complexation with beta-cyclodextrin 92
The inclusion complexes of hesperetin and its 7-rhamnoglucoside with (2-hydroxypropyl)-beta-cyclodextrin 92
FLUORIMETRIC STUDY OF b-BLOCKERS/b-CYCLODEXTRINS INCLUSION COMPLEXES 91
STRUCTURAL AND CONFORMATIONAL STUDY OF BETA-BLOCKERS/BETA-CYCLODEXTRIN COMPLEXES 90
PROFILI TEMPERATURA-VELOCITA' DA CINETICHE POLARIMETRICHE A TEMPERATURA VARIABILE 90
HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY AND DIFFUSE REFLECTANCE SPECTROSCOPY OF FLAVONOIDS IN CRATEGUS-OXYACANTHA L .3. ANALYSIS OF 2-PHENYL-CHROMAN DERIVATIVES AND CAFFEIC ACID 90
CROMATOGRAFIA LIQUIDA AD ALTA RISOLUZIONE NELL'ANALISI DI PREPARAZIONI ESTRATTIVE DI FOGLIE E GERMOGLI DI OLEA EUROPAEA L. 89
CROMATOGRAFIA LIQUIDA NELL'ANALISI FARMACEUTICA: SEPARAZIONE E DETERMINAZIONE DI FAMOTIDINA, NUOVO H2-ANTAGONISTA 89
ISOFLAVONES AND CYCLODEXTRINS: EVIDENCES OF COMPLEXATION BY COMPLEMENTARY SPECTROSCOPIC TECHNIQUES 89
Diastereo-enantioseparation of N-Acetyl-1-aryl-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline derivatives on cellulose chiral stationary phases 88
Temperature-rate profiles by polarimetric variable-temperature kinetic experiments to study racemization reactions 88
PHARMACEUTICAL APPLICATION OF BETA-CYCLODEXTRIN: INCLUSION COMPLEXES WITH BETA-BLOCKERS 88
IMPROVEMENT OF FLAVONOIDS DISSOLUTION PROPERTIES BY COMPLEXATION WITH BETA-CYCLODEXTRIN 87
Nuclear magnetic resonance of psychotherapeutic agents. IV. Conformational analysis of 2,3-dihydro.1H-1,4-benzodiazepines 87
FTIR-ATR spectroscopy to probe selective protein recognition by cyclodextrin nanoaggregates 86
Validation of variable-parameter kinetic methods for accelerated studies on drug stability 86
PREPARATION AND CHARACTERIZATION OF GEMCITABINE-LOADED CHITOSAN MICROSPHERES 86
VALIDATION OF A LIQUID CROMATOGRAPHIC METHOD FOR THE ANALYSIS OF ZAFIRLUKAST IN A PHARMACEUTICAL FORMULATION 85
MODIFIED CYCLODEXTRINS IN THE SOLUBILIZATION OF SOME PHYTOESTROGENS 84
FORCE FIELD COMPARISONS AND CONFORMATIONAL ANALYSIS OF STRUCTURES INTERESTING IN PHARMACEUTICAL RESEARCH. 84
Diastereo-enantioseparation of novel gamma-lactamic derivatives on cellulose chiral stationary phases 83
STRUCTURAL AND THERMODYNAMIC STUDY OF BETA-BLOCKERS/BETA-CYCLODEXTRIN INCLUSION COMPLEXES 83
Study of the inclusion complex of atenolol with beta- cyclodextrins 83
Dosaggio HPLC della roxatidina, prove di stabilità e rilascio da formulazioni farmaceutiche. 83
ENANTIOMERIC SEPARATION BY HPLC OF FLAVANONES AND FLAVANS WITH ANTIOXYDANT ACTIVITY. 83
Risonanza magnetica nucleare di 1,4-benzodiazepine. Accoppiamento attraverso lo spazio di 2,3-diidro-1H-1,4-benzodiazepine 1-sostituite 83
STUDIO COMPARATIVO DI RISOLUZIONE ENANTIOMERICA DI NUOVI DERIVATI 2,3-BENZODIAZEPINICI AD ATTIVITA' ANTICONVULSIVANTE SU FASI STAZIONARIE CHIRALI DI NATURA POLISACCARIDICA. 82
HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY OF FLAVONOIDS IN CRATAEGUS-OXYACANTHA L .4. REVERSED-PHASE HIGH-PRESSURE LIQUID- CHROMATOGRAPHY IN FLOWER, LEAF AND BUD EXTRACTIVES OF CRATAEGUS-OXYACANTHA L 81
Nuclear magnetic resonance of 1,4-benzodiazepines. II. Stereochemistry of 1,3-dihydro-2H-1,4-benzodiazepin-2-ones by lanthanide shift reagents 81
PHOTODEGRADATION STUDY ON 3-HYDROXYFLAVONE BY HPLC. 80
MODELLO DI INTERAZIONE SELECTORS-SELCTANDS NEL PROCESSO DI DISCRIMINAZIONE CHIRALE. 80
Validation of a LC method for the analysis of zafirlukast in a pharmaceutical formulation 80
USE OF DIFFERENT CYCLODEXTRINS AS SOLUBILIZING AGENTS 79
Isolation and characterization of Guiera senegalensis J.F.Gmel. active principles. 79
Nuclear magnetic resonance spectra of psychotherapeutic agents. V. Conformational analysis of 1,3,4,5-tetrahydro-2H-1,5-benzodiazepin-2-ones 79
SIMULTANEOUS DETERMINATION OF METAPROLOL AND HYDROCLOROTHIAZIDE IN TWO COMPONENT TABLET FORMULATIONS BY HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY 78
STRUCTURE OF BETA-BLOCKERS/BETA-CYCLODEXTRIN INCLUSION COMPLEX BY NMR, X-RAY AND DSC INVESTIGATION 78
SPECTROSCOPIC STUDIES ON THE QUERCETIN/(2-HYDROXYPROPYL)-B-CYCLODEXTRIN INTERACTIONS 78
DETERMINAZIONE DELLA STABILITA' DI PRODOTTI DI INTERESSE FARMACEUTICO. 78
FTIR-ATR SPECTROSCOPY TO PROBE SELECTIVE PROTEIN RECOGNITION BY CYCLODEXTRIN NANOAGGREGATES 77
OTTIMIZZAZIONE DI UN METODO ELETTROFORETICO PER L'ANALISI DI ISOFLAVONI E COUMESTANI 77
Totale 10.299
Categoria #
all - tutte 45.608
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 45.608


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021505 0 0 0 0 0 133 6 130 1 82 125 28
2021/2022966 5 210 10 14 21 2 66 40 4 118 177 299
2022/20232.415 175 179 123 155 216 235 38 137 1.032 10 92 23
2023/2024411 65 75 34 50 39 81 6 14 0 16 2 29
2024/20252.313 36 36 38 157 88 40 39 517 585 126 217 434
2025/20263.907 347 406 475 493 587 1.599 0 0 0 0 0 0
Totale 13.010